ARTICLE | Clinical News
Isis regulatory update
February 12, 1996 8:00 AM UTC
ISIP received U.S. Patent No. 5,489,677 covering methylene methyl imino (MMI) and related chemical constructs used to link together the bases in antisense drugs. MMI linkage allows the creation of bac...